SCHEMBL6939872

SCHEMBL6939872

CNCCCCCCOC

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.50
ALDH1A1 P00352 3/20 0.41
L3MBTL4 Q8NA19 1/20 0.40
L3MBTL3 Q96JM7 1/20 0.40
L3MBTL1 Q9Y468 4/20 0.38
GAA P10253 1/20 0.38
SLC6A4 P31645 1/20 0.37
SIGMAR1 Q99720 2/20 0.37
TSHR P16473 2/20 0.37
HTR1B P28222 1/20 0.37
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14380141 1.00 EPHX1 (0.50) EPHX1ALDH1A1L3MBTL4L3MBTL3L3MBTL1
SCHEMBL24922155 1.00 EPHX1 (0.50) EPHX1ALDH1A1L3MBTL4L3MBTL3L3MBTL1
SCHEMBL24130543 1.00 EPHX1 (0.50) EPHX1ALDH1A1L3MBTL4L3MBTL3L3MBTL1
SCHEMBL6936242 1.00
SCHEMBL24922150 1.00 EPHX1 (0.50) EPHX1ALDH1A1L3MBTL4L3MBTL3L3MBTL1
SCHEMBL24922153 1.00 EPHX1 (0.50) EPHX1ALDH1A1L3MBTL4L3MBTL3L3MBTL1
SCHEMBL24130676 1.00 EPHX1 (0.50) EPHX1ALDH1A1L3MBTL4L3MBTL3L3MBTL1
SCHEMBL24922156 1.00 EPHX1 (0.50) EPHX1ALDH1A1L3MBTL4L3MBTL3L3MBTL1
SCHEMBL24922151 1.00 EPHX1 (0.50) EPHX1ALDH1A1L3MBTL4L3MBTL3L3MBTL1
SCHEMBL14969519 1.00 EPHX1 (0.50) EPHX1ALDH1A1L3MBTL4L3MBTL3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4328310-A1 SIRNA TARGETING 17B-HYDROXYSTEROID DEHYDROGENASE TYPE 13 AND SIRNA CONJUGATE Tuojie Biotech (Shanghai) Co., Ltd. (CN) 2024-02-28 EP disclosed
EP-4194553-A1 MODIFIED SIRNA WITH REDUCED OFF-TARGET ACTIVITY Tuojie Biotech (Shanghai) Co., Ltd. (CN) 2023-06-14 EP disclosed
WO-2023041079-A9 LPA INHIBITOR AND USE THEREOF 上海金中锘美生物医药科技有限公司 2023-06-01 WO disclosed
WO-2023006097-A1 BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER 海创药业股份有限公司 2023-02-02 WO disclosed
WO-2022118186-A1 SENOTHERAPEUTIC COMPOUND BIONEXA S.R.L. (IT) 2022-06-09 WO disclosed
WO-2021254360-A1 CARBOHYDRATE MOLECULAR CLUSTER AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 上海拓界生物医药科技有限公司 2021-12-23 WO disclosed
EP-3733187-A1 CHIRAL DIARYL MACROCYCLE AND USE THEREOF IN THE TREATMENT OF CANCER Turning Point Therapeutics, Inc. (US) 2020-11-04 EP disclosed
WO-2019008537-A9 MEDICAL COMPOUNDS VERA SALUS RICERCA S.R.L. (IT) 2020-02-20 WO disclosed
WO-2019008537-A1 MEDICAL COMPOUNDS VERA SALUS RICERCA S.R.L. (IT) 2019-01-10 WO disclosed
EP-0805674-B1 SKIN AND HAIR COSMETIC COMPOSITIONS KAO CORP (JP) 2003-03-12 EP disclosed
US-6348200-B1 OXYALKYLAMIDE OR AMINE DERIVATIVES;AT LEAST ONE OF POLYHYDRIC ALCOHOLS, OR VEGETABLE EXTRACTS, OR ORGANIC ACIDS; IMPROVES WATER-RETAINING ABILITY OF HORNY LAYER, CURES ROUGHNESS AND PREVENTS WRINKLES KAO CORPORATION (JP) 2002-02-19 US disclosed
US-6187955-B1 A MOISTURIZER FOR SOFTENING SKINS; USEFUL AS COMPONENTS OF COSMETIC FORMULATIONS KAO CORPORATION (JP) 2001-02-13 US disclosed
US-5723133-A GUANIDINE WITH ORGANIC ACID FOR SKIN SOFTENING KAO CORPORATION (JP) 1998-03-03 US disclosed
EP-0805674-A1 SKIN AND HAIR COSMETIC COMPOSITIONS Kao Corporation (JP) 1997-11-12 EP disclosed
WO-1997014401-A1 SKIN AND HAIR COSMETIC COMPOSITIONS KAO CORPORATION (JP) 1997-04-24 WO disclosed